Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474577 · ClinicalTrials.gov registry record
Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT01474577: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01474577 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01474577 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?
Primary Outcome
Patients will complete one questionnaire over the phone.
Interventions
- OTHER questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2011-11-08 |
| Est. Completion | 2017-05-18 |
What the finished NCT01474577 record still lists
NCT01474577 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which questionnaire is the first listed.
NCT01474577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01474577 about?
NCT01474577 is a clinical study titled "Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging". The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?
What is the current status of trial NCT01474577?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2011-11-08. Estimated completion is 2017-05-18.
What interventions are being tested in trial NCT01474577?
The interventions under investigation include: questionnaire (OTHER).
Who is sponsoring clinical trial NCT01474577?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI